Specialty· August 10, 2026 · 19 min readDermatomyositis Treatment Access (2026): Brepocitinib, Octagam IVIG, and DMARDsPayer access guide for dermatomyositis (DM) therapies in 2026. Prior authorization, step therapy, Octagam IVIG, off-label DMARDs, and...By Ran Chen#Dermatomyositis#Specialty Pharmacy#Payer Policy
